Pharmala Biotech Pink Sheet Forecast - Naive Prediction

Summary

PMBHFDelisted Stock

0.25 0.00 0.00%

The Naive Prediction forecasted value of Pharmala Biotech Holdings on the next trading day is expected to be 0.17 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 0.96. Investors can use prediction functions to forecast Pharmala Biotech's stock prices and determine the direction of Pharmala Biotech Holdings's future trends based on various well-known forecasting models. However, exclusively looking at the historical price movement is usually misleading. We recommend always using this module together with an analysis of Pharmala Biotech's historical fundamentals, such as revenue growth or operating cash flow patterns. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

A naive forecasting model for Pharmala Biotech is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Pharmala Biotech Holdings value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

More About Naive Prediction All Equity Analysis

Pharmala Biotech Naive Prediction Price Forecast For the 15th of December 2024

Given 90 days horizon, the Naive Prediction forecasted value of Pharmala Biotech Holdings on the next trading day is expected to be 0.17 with a mean absolute deviation of 0.02, mean absolute percentage error of 0.0009, and the sum of the absolute errors of 0.96.

Please note that although there have been many attempts to predict Pharmala Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Pharmala Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Pharmala Biotech Pink Sheet Forecast Pattern

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Pharmala Biotech pink sheet data series using in forecasting. Note that when a statistical model is used to represent Pharmala Biotech pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.

AIC	Akaike Information Criteria	81.637
Bias	Arithmetic mean of the errors	None
MAD	Mean absolute deviation	0.0213
MAPE	Mean absolute percentage error	0.0853
SAE	Sum of the absolute errors	0.9567

This model is not at all useful as a medium-long range forecasting tool of Pharmala Biotech Holdings. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Pharmala Biotech. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Pharmala Biotech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pharmala Biotech Holdings. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Pharmala Biotech. Your research has to be compared to or analyzed against Pharmala Biotech's peers to derive any actionable benefits. When done correctly, Pharmala Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Pharmala Biotech Holdings.

Pharmala Biotech Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pharmala Biotech pink sheet to make a market-neutral strategy. Peer analysis of Pharmala Biotech could also be used in its relative valuation, which is a method of valuing Pharmala Biotech by comparing valuation metrics with similar companies.

CECO Environmental Corp Sabre Corpo Warner Music Group Universal Music Group PVH Corp Chester Mining Sandstorm Gold Ltd American Airlines Group Alcoa Corp Apple Inc Best Buy Co Citigroup SentinelOne CVS Health Corp Chevron Corp

Risk & Return

Correlation

Pharmala Biotech Market Strength Events

Market strength indicators help investors to evaluate how Pharmala Biotech pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pharmala Biotech shares will generate the highest return on investment. By undertsting and applying Pharmala Biotech pink sheet market strength indicators, traders can identify Pharmala Biotech Holdings entry and exit signals to maximize returns.

	Rate Of Daily Change	1.0
	Day Median Price	0.25
	Day Typical Price	0.25

Pharmala Biotech Risk Indicators

The analysis of Pharmala Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Pharmala Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pharmala pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.

	Mean Deviation	4.56
	Semi Deviation	6.16
	Standard Deviation	14.89
	Variance	221.85
	Downside Variance	248.2
	Semi Variance	37.89
	Expected Short fall	(25.35)

Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Consideration for investing in Pharmala Pink Sheet

If you are still planning to invest in Pharmala Biotech Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pharmala Biotech's history and understand the potential risks before investing.

	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Global Correlations Find global opportunities by holding instruments from different markets
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC